Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Cryo-Cell International Inc. (CCEL) had Revenue of $31.99M for the most recently reported fiscal year, ending 2024-11-30.

Quarterly Annual

Figures for fiscal year ending 2024-11-30

Income Statement Financials
Revenue	$31.99M
Net Income	$0.40M
Cost of Goods Sold	$7.95M
Gross Profit	$24.04M
Operating Expenses	$28.51M
Operating Income	$3.48M
Non-Operating Income/Expense	$-0.68M
Pre-Tax Income	$2.80M
Normalized Pre-Tax Income	$1.73M
Income after Taxes	$0.40M
Income from Continuous Operations	$0.40M
Consolidated Net Income/Loss	$0.40M
Normalized Income after Taxes	$-1.60M
EBIT	$3.48M
EBITDA	$4.52M
Weighted-Average Shares Outstanding (Basic)	8.13M
Weighted-Average Shares Outstanding (Diluted)	8.21M
Earnings per Share (EPS) (Basic)	$0.05
Earnings per Share (EPS) (Diluted)	$0.05
Balance Sheet Financials
Current Assets	$12.55M
Property, Plant, and Equipment	$21.89M
Long-Term Assets	$52.12M
Total Assets	$64.68M
Current Liabilities	$21.60M
Long-Term Debt	$8.31M
Long-Term Liabilities	$56.29M
Total Liabilities	$77.89M
Common Equity	$-13.22M
Tangible Shareholders Equity	$-16.08M
Shareholders Equity	$-13.22M
Common Shares Outstanding	8.08M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.01M
Cash Flow from Investing Activities	$-4.88M
Cash Flow from Financial Activities	$-0.98M
Beginning Cash	$0.41M
End Cash	$0.56M
Increase/Decrease in Cash	$0.15M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-2.02M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.58
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-1.69
Debt to Equity Ratio	-0.91
Gross Margin	75.15%
Operating Margin	10.88%
EBIT Margin	10.88%
EBITDA Margin	14.14%
Pre-Tax Profit Margin	8.77%
Profit Margin	1.26%
Free Cash Flow	$3.61M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.49
Inventory Turnover	12.08
Receiveable Turnover	4.38
Days Sales in Receivables	83.41
Return on Equity	-3.04%
Return on Tangible Equity	-2.50%
Return on Assets	0.62%
Return on Investments	-8.20%
Book Value Per Share	$-1.64
Free Cash Flow per Share	$0.44
Operating Cash Flow per Share	$0.73

Data from Zacks Investment Research, Inc.